{
    "Additional Indicators": [
        {
            "description": "Unfavorable Prognosis",
            "therapy": "NCCN, Consensus, Non-Small Cell Lung Cancer",
            "mutation": "KRASp.G12C Gain-of-function"
        }
    ],
    "Clinical trials": [
        {
            "description": "A Study of VS-6766 v. VS-6766 + Defactinib in Recurrent G12V, Other KRAS and BRAF Non-Small Cell Lung Cancer ",
            "phase": "Phase 2",
            "mutations": [
                "KRAS"
            ]
        },
        {
            "description": "A Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1",
            "phase": "Phase 1/2",
            "mutations": [
                "KRAS",
                "STK11"
            ]
        },
        {
            "description": "First-in-human Study of DRP-104 (Sirpiglenastat) as Single Agent and in Combination With Atezolizumab in Patients With Advanced Solid Tumors. (NCT04471415)",
            "phase": "Phase 1/2",
            "mutations": [
                "NFE2L2",
                "STK11"
            ]
        }
    ],
    "variants of unknown significance": {
        "Somatic": [
            {
                "Gene": "NTRK1",
                "DNA Alteration": "c.1792C>T",
                "GeneMutation": "p.G607V Spliceregionvariant-LOF",
                "VariantAlleleFraction": "7.48%"
            },
            {
                "Gene": "FGFR3",
                "DNA Alteration": "c.746C>G",
                "GeneMutation": "p.K650E Nonsense-LOF",
                "VariantAlleleFraction": "12.77%"
            },
            {
                "Gene": "TEK",
                "DNA Alteration": "c.1354A>G",
                "GeneMutation": "p.N452D Spliceregionvariant-LOF",
                "VariantAlleleFraction": "12.68%"
            },
            {
                "Gene": "PAX5",
                "DNA Alteration": "c.547G>A",
                "GeneMutation": "p.A322T Missensevariant(exon2)-GOF",
                "VariantAlleleFraction": "8.76%"
            },
            {
                "Gene": "BRCA1",
                "DNA Alteration": "c.5265_5266insC",
                "GeneMutation": "p.E23Vfs*17 Missensevariant(exon2)-GOF",
                "VariantAlleleFraction": "2.29%"
            },
            {
                "Gene": "BLM",
                "DNA Alteration": "c.2207_2212delinsTAGATTC",
                "GeneMutation": "p.Y736fs*4 Stopgain-LOF",
                "VariantAlleleFraction": "8.0%"
            },
            {
                "Gene": "HBA2",
                "DNA Alteration": "c.427T>C",
                "GeneMutation": "p.*143Qext*31 Missensevariant(exon2)-GOF",
                "VariantAlleleFraction": "2.92%"
            },
            {
                "Gene": "STAG2",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.R1012X Frameshift-LOF",
                "VariantAlleleFraction": "6.99%"
            },
            {
                "Gene": "CTNNB1",
                "DNA Alteration": "c.110C>T",
                "GeneMutation": "p.S45F Nonsense-GOF",
                "VariantAlleleFraction": "2.83%"
            },
            {
                "Gene": "CDKN2A",
                "DNA Alteration": "c.151G>A",
                "GeneMutation": "p.H83Y Frameshift-GOF",
                "VariantAlleleFraction": "6.99%"
            },
            {
                "Gene": "KLF1",
                "DNA Alteration": "c.892G>C",
                "GeneMutation": "p.M39L Missensevariant(exon2)-GOF",
                "VariantAlleleFraction": "3.39%"
            },
            {
                "Gene": "ERBB2",
                "DNA Alteration": "c.2089G>T",
                "GeneMutation": "p.I655V Frameshift-GOF",
                "VariantAlleleFraction": "3.46%"
            }
        ],
        "Germline": []
    }
}